Effect of Dexmedetomidine After Thyroidectomy

Sponsor
Chosun University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT02412150
Collaborator
(none)
139
1
2
79.8
1.7

Study Details

Study Description

Brief Summary

The purpose of the present study was to compare the effect of dexmedetomidine which is administered during emergence in adult patients undergoing elective thyroidectomy on smooth emergence form general anesthesia (reducing agitation or coughing, signs of hypertension or tachycardia, or etc.) and postoperative outcome (postoperative bleeding and hospital staying).

Condition or Disease Intervention/Treatment Phase
  • Drug: Desflurane
  • Drug: Remifentanil
  • Procedure: Thyroidectomy
  • Other: Vital signs
  • Behavioral: Cough reflex
  • Behavioral: Ramsay Sedation Scale
  • Other: Extubation time and Recovery time
  • Behavioral: Visual analogue scale
  • Other: Postoperative bleeding
  • Other: Postoperative complications
  • Other: Time to remove drainage and duration of hospital staying
  • Drug: Dexmedetomidine
  • Drug: Normal saline
N/A

Detailed Description

Smooth emergence from general anaesthesia after surgery is important to prevent potentially dangerous effects such as hypertension, tachycardia, myocardial ischaemia, arrhythmias and increased intracranial and intra-abdominal pressure. After thyroidectomy, activities during emergence such as agitation or coughing, signs of hypertension or tachycardia, or etc. may lead to postoperative bleeding, resulting in acute airway obstruction or reoperation.

The purpose of the present study was to compare the effect of dexmedetomidine which is administered during emergence in adult patients undergoing elective thyroidectomy on smooth emergence form general anesthesia and postoperative outcome.

Study Design

Study Type:
Interventional
Actual Enrollment :
139 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Effect of Dexmedetomidine Infusion for Postoperative Outcome and Smooth Emergence After Thyroidectomy
Study Start Date :
Apr 1, 2014
Actual Primary Completion Date :
Nov 21, 2020
Actual Study Completion Date :
Nov 25, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Dexmedetomidine (Group D)

After induction of anesthesia, anesthesia is maintained with desflurane and remifentanil during thyroidectomy. Fifteen minutes before the end of surgery, infusion of remifentanil for surgery is discontinued. Then, dexmedetomidine has started infusion for 15 min (rate of 0.6 ug/kg/hr). Vital signs and complications of testing drugs are measured before and after infusion of testing drugs. Five minutes before the end of surgery, anesthetic gas (desflurane) is discontinued. After patient has awake, extubation has done. Extubation time and Recovery time,Cough reflex,Ramsay Sedation Scale, Visual analogue scale, and surgical outcomes such as postoperative bleeding, time to remove drainage and duration of hospital staying, postoperative complications are measured until POD#3.

Drug: Desflurane
Anesthesia is maintained with desflurane
Other Names:
  • Anesthetic gas
  • Drug: Remifentanil
    Remifentanil is infused for the maintenance of anesthesia during surgery and discontinued 15 min before end of surgery
    Other Names:
  • Opioid
  • Procedure: Thyroidectomy
    The aim of this study is evaluation of effect of dexmedetomidine on emergence response and postoperative outcome after thyroidectomy
    Other Names:
  • Surgery
  • Other: Vital signs
    Systolic blood pressure, diastolic blood pressure, mean arterial pressure, and heart rate are measured before infusion of testing drugs, after infusion of them (5 min, 10 min, and 15 min), during extubation (0 min and 5 min after extubation), and at recovery room. And the complications such as hypotension, hypertension, bradycardia, tachycardia, and desaturation after infusion of testing drugs are observed.
    Other Names:
  • Hemodynamics
  • Behavioral: Cough reflex
    During recovery from anesthesia at operation room, cough reflex is measured and rated. [Grade 0, no cough; Grade 1, single cough with mild severity; Grade 2, cough persistence less than 5 s with moderate severity; Grade 3, severe, persistent cough for more than 5 s (bucking)]

    Behavioral: Ramsay Sedation Scale
    When the patient has fully awaken and transferred to the recovery room, Ramsay Sedation Scale is measured. Awake Patient anxious and agitated or restless or both! Patient cooperative, oriented and tranquil! Patient responds to commands only! Asleep A brisk response to a light glabellar tap or loud auditory stimulus! A sluggish response to a light glabellar tap or loud auditory stimulus! No response to a light glabellar tap or loud auditory stimulus
    Other Names:
  • RSS
  • Other: Extubation time and Recovery time
    The time from discontinuing anesthetic gas to endotracheal extubation is measured. And the time from the discontinuing of anesthetic gas to transferring to the recovery room is also measured.

    Behavioral: Visual analogue scale
    The severity of pain after surgery is measured by VAS (at recovery room, POD 1, POD 2, and POD 3)
    Other Names:
  • VAS
  • Other: Postoperative bleeding
    The amount of postoperative bleeding which is collected in the barovac is measured.

    Other: Postoperative complications
    Postoperative complications after thyroidectomy such as hoarseness and hematoma, and reoperation due to such complication is observed.

    Other: Time to remove drainage and duration of hospital staying
    The time from the end of surgery to remove drainage is measured. And the duration of hospital staying is measured.

    Drug: Dexmedetomidine
    Dexmedetomidine has started infusion for 15 min (rate of 0.6 ug/kg/hr) before end of surgery as experimental intervention
    Other Names:
  • Precedex
  • Placebo Comparator: Normal Saline (Group N)

    After induction of anesthesia, anesthesia is maintained with desflurane and remifentanil during thyroidectomy. Fifteen minutes before the end of surgery, infusion of remifentanil for surgery is discontinued. Then, normal saline has started infusion for 15 min (same rate as Group D). Vital signs and complications of testing drugs are measured before and after infusion of testing drugs. Five minutes before the end of surgery, anesthetic gas (desflurane) is discontinued. After patient has awake, extubation has done. Extubation time and Recovery time,Cough reflex,Ramsay Sedation Scale, Visual analogue scale, and surgical outcomes such as postoperative bleeding, time to remove drainage duration of hospital staying, postoperative complications are measured until POD#3.

    Drug: Desflurane
    Anesthesia is maintained with desflurane
    Other Names:
  • Anesthetic gas
  • Drug: Remifentanil
    Remifentanil is infused for the maintenance of anesthesia during surgery and discontinued 15 min before end of surgery
    Other Names:
  • Opioid
  • Procedure: Thyroidectomy
    The aim of this study is evaluation of effect of dexmedetomidine on emergence response and postoperative outcome after thyroidectomy
    Other Names:
  • Surgery
  • Other: Vital signs
    Systolic blood pressure, diastolic blood pressure, mean arterial pressure, and heart rate are measured before infusion of testing drugs, after infusion of them (5 min, 10 min, and 15 min), during extubation (0 min and 5 min after extubation), and at recovery room. And the complications such as hypotension, hypertension, bradycardia, tachycardia, and desaturation after infusion of testing drugs are observed.
    Other Names:
  • Hemodynamics
  • Behavioral: Cough reflex
    During recovery from anesthesia at operation room, cough reflex is measured and rated. [Grade 0, no cough; Grade 1, single cough with mild severity; Grade 2, cough persistence less than 5 s with moderate severity; Grade 3, severe, persistent cough for more than 5 s (bucking)]

    Behavioral: Ramsay Sedation Scale
    When the patient has fully awaken and transferred to the recovery room, Ramsay Sedation Scale is measured. Awake Patient anxious and agitated or restless or both! Patient cooperative, oriented and tranquil! Patient responds to commands only! Asleep A brisk response to a light glabellar tap or loud auditory stimulus! A sluggish response to a light glabellar tap or loud auditory stimulus! No response to a light glabellar tap or loud auditory stimulus
    Other Names:
  • RSS
  • Other: Extubation time and Recovery time
    The time from discontinuing anesthetic gas to endotracheal extubation is measured. And the time from the discontinuing of anesthetic gas to transferring to the recovery room is also measured.

    Behavioral: Visual analogue scale
    The severity of pain after surgery is measured by VAS (at recovery room, POD 1, POD 2, and POD 3)
    Other Names:
  • VAS
  • Other: Postoperative bleeding
    The amount of postoperative bleeding which is collected in the barovac is measured.

    Other: Postoperative complications
    Postoperative complications after thyroidectomy such as hoarseness and hematoma, and reoperation due to such complication is observed.

    Other: Time to remove drainage and duration of hospital staying
    The time from the end of surgery to remove drainage is measured. And the duration of hospital staying is measured.

    Drug: Normal saline
    Normal saline has started infusion for 15 min (as same rate of dexmedetomidine) before end of surgery as control intervention
    Other Names:
  • NS
  • Outcome Measures

    Primary Outcome Measures

    1. Postoperative bleeding [From the end of surgery to the 3rd postoperative day (an expected average of 3 days)]

      Postoperative bleeding: Sum of bleeding via barovac

    Secondary Outcome Measures

    1. Ramsay Sedation scale [During the recovery time of anesthesia, an expected average of 20 min]

      Ramsay Sedation scale at recovery room

    2. Extubation time [During the recovery time of anesthesia, an expected average of 20 min]

      time to extubation from the end of surgery

    3. Recovery time of anesthesia [During the recovery time of anesthesia, an expected average of 20 min]

      time to transfer to recovery room from the end of surgery

    4. Duration of hospital stay [Participants will be followed for the duration of hospital stay, an expected average of 1 week]

      Duration of hospital stay

    5. Pain score [From the end of surgery to the 3rd postoperative day (an expected average of 3 days)]

      Pain score: NRS

    6. Incidence of postoperative complications [Participants will be followed for the duration of hospital stay, an expected average of 1 week]

      Hoarseness, hematoma, and reoperation

    7. Coughing Response [During the recovery time of anesthesia, an expected average of 20 min]

      Coughing Response during recovery from anesthesia

    Other Outcome Measures

    1. Vital signs [From 15 min before the end of surgery to the time when the patient has transferred to the recovery room, an expected average of 40 min]

      Systolic blood pressure, diastolic blood pressure, mean arterial pressure, and heart rate

    2. Complications of testing drug [During infusion of testing drug (15 min)]

      Hypertension, hypotension, bradycardia, tachycardia, and desaturation after infusion of dexmedetomidine or normal saline

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years to 60 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Female patient,

    • Aged 20-60 yr,

    • ASA physical status 1-2,

    • Patients undergoing elective thyroidectomy under general anesthesia

    Exclusion Criteria:
    • Sighs of difficult airway,

    • History of respiratory disease or chronic cough,

    • Cardiovascular disease,

    • Pregnant or breast-feeding woman

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Chosun University Hospital Gwangju Donggu Korea, Republic of 501-717

    Sponsors and Collaborators

    • Chosun University Hospital

    Investigators

    • Study Chair: Ki Tae Jung, M.D., Chosun University Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Ki Tae Jung, Assist Professor, Chosun University Hospital
    ClinicalTrials.gov Identifier:
    NCT02412150
    Other Study ID Numbers:
    • DEX_ENT
    • 2014-04-004-003
    First Posted:
    Apr 9, 2015
    Last Update Posted:
    Nov 27, 2020
    Last Verified:
    Nov 1, 2020

    Study Results

    No Results Posted as of Nov 27, 2020